| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Non-Customized |
|
Still deciding? Get samples of US$ 5/g
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Name | Lomustine |
| CAS No. | 13010-47-4 |
| EINECS | 235-859-2 |
| MF | C9H16ClN3O2 |
| MW | 233.7 |
Uses: CCNU is an oral anticancer drug that was approved by the U.S. Food and Drug Administration in 1976 for marketing, as lomustine . CCNU is used alone or in combination with other antineoplastic agents, including procarbazine and vincristine, etoposide and prednimustine, and other combinations (IARC 1981, HSDB 2009). It is used primarily in the treatment of Hodgkin's disease and brain tumors, but it has also been used to treat other cancer, includ-ing lung cancer, non-Hodgkin's lymphoma, malignant melanoma, breast cancer, kidney cancer, and cancer of the gastrointestinal tract . It has also been applied to the skin to treat mycosis fungoides and psoriasis.
Uses: Lomustine USP is used to treat Malignant brain tumors; Hodgkin's disease.
Uses :Chloroethylnitrosourea derivative with antitumor activity. Similar to carmustine, chlorozotocin, nimustine, ranimustine. Antineoplastic.
){kind=link}